Document is current
Any future updates will be listed below
-
Authors
Zandi, Peter P. https://orcid.org/0000-0001-8423-2623
Jaffe, Andrew E. https://orcid.org/0000-0001-6886-1454
Goes, Fernando S. https://orcid.org/0000-0001-6262-8264
Burke, Emily E.
Collado-Torres, Leonardo https://orcid.org/0000-0003-2140-308X
Huuki-Myers, Louise
Seyedian, Arta
Lin, Yian
Seifuddin, Fayaz https://orcid.org/0000-0003-3357-7888
Pirooznia, Mehdi https://orcid.org/0000-0002-4210-6458
Ross, Christopher A.
Kleinman, Joel E. https://orcid.org/0000-0002-4210-6052
Weinberger, Daniel R. https://orcid.org/0000-0003-2409-2969
Hyde, Thomas M. https://orcid.org/0000-0002-8746-3037
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH105898, R01MH105898, R01MH105898, R01MH105898, R01MH105898, R01MH105898, R01MH105898, R01MH105898, R01MH105898)
- License Information
-
More Information
Article History
Received: 12 January 2021
Accepted: 26 January 2022
First Online: 7 March 2022
Competing interests
: A.E.J. is now a full-time employee and shareholder of Neumora Therapeutics, a for-profit biotechnology company, which is unrelated to the contents of this manuscript. D.R.W. is on the scientific advisory board of Sage Therapeutics. All other authors report no competing interests.
